학술논문
Personalising care: using infliximab drug trough and anti-drug antibody levels improves clinical treatment decisions and is a cost-effective strategy in spondyloarthritis
Document Type
Article
Author
Source
In Clinical Medicine March 2019 19(2) Supplement:s106-s107
Subject
Language
ISSN
1470-2118